Therefore, they are nowadays recommended as first line therapy in patients with T2DM and atherosclerotic cardiovascular disease to reduce events, regardless of baseline or target HbA1c and concomitant glucose-lowering medication according to the 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes [31]
When methylation and energy metabolism are aligned, ATP production stabilizes, oxidative stress declines, and cognitive and behavioral symptoms often improve
Do not use during pregnancy, breastfeeding and stop at least 2 months before a planned pregnancy
How it stacks up to retatrutide
But what happens when your experience doesnt match what you anticipated
Eligible people can receive prescriptions for Food and Drug Administration (FDA)-approved GLP-1 medications, including: This includes new GLP-1 options such as the Wegovy pill, Zepbound KwikPen, and Foundayo